Mark E Schurdak

Title: Mark E Schurdak: Innovator in High Throughput Screening Technology

Introduction

Mark E Schurdak is a notable inventor based in Antioch, IL (US). He has made significant contributions to the pharmaceutical industry through his innovative work in high throughput screening technology. His expertise and dedication have led to the development of a unique patent that enhances the efficiency of drug discovery processes.

Latest Patents

Mark E Schurdak holds a patent for Continuous Format High Throughput Screening (CF-HTS). This technology utilizes at least one porous matrix to allow the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. Additionally, CF-HTS is beneficial for performing multi-step assays, making it a valuable tool in the field of drug development.

Career Highlights

Mark is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Bruce A Beutel and Martin J Voorbach. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark E Schurdak's contributions to high throughput screening technology exemplify his commitment to advancing the pharmaceutical industry. His patent and work at Abbott Laboratories Corporation highlight his role as a key innovator in this vital field.